Perspectives on Outsourcing

Dec 01, 2016
BioPharm International
Biosimilars may be the key to CMO growth.
Nov 01, 2016
BioPharm International
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 01, 2016
BioPharm International
This key bioprocessing segment is expecting continued growth.
Sep 01, 2016
BioPharm International
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Aug 01, 2016
BioPharm International
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
Jul 02, 2016
BioPharm International
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
Jun 02, 2016
BioPharm International
Acquisition binges often lead to hangovers; here’s what to watch out for.
May 01, 2016
BioPharm International
Growth may be slowing, but outsourcing activity remains healthy.
Apr 01, 2016
BioPharm International
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
Mar 01, 2016
BioPharm International
By BioPharm International Editors
The biopharmaceutical outsourcing market starts 2016 with company expansions, acquisitions, and new offerings.
native1_300x100
lorem ipsum